Cho HJ - Search Results

1

Response to gemcitabine-platinum chemotherapy by single nucleotide polymorphisms of RRM1 and ERCC1 genes in patients with non-small-cell lung cancer.

Oh IJ, Ban HJ, Kim KS, Song SY, Na KJ, Kim YH, Ahn SJ, Choi S, Cho HJ, Kim YC. Oh IJ, et al. Among authors: cho hj. Thorac Cancer. 2012 Feb;3(1):19-26. doi: 10.1111/j.1759-7714.2011.00082.x. Thorac Cancer. 2012. PMID: 28920258 Free article.

2

Efficacy of gemcitabine in patients with non-small cell lung cancer according to promoter polymorphisms of the ribonucleotide reductase M1 gene.

Kim SO, Jeong JY, Kim MR, Cho HJ, Ju JY, Kwon YS, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC. Kim SO, et al. Among authors: cho hj. Clin Cancer Res. 2008 May 15;14(10):3083-8. doi: 10.1158/1078-0432.CCR-07-4591. Clin Cancer Res. 2008. PMID: 18483375

3

Disease-free survival of patients after surgical resection of non-small cell lung carcinoma and correlation with excision repair cross-complementation group 1 expression and genotype.

Tseden-Ish M, Choi YD, Cho HJ, Ban HJ, Oh IJ, Kim KS, Song SY, Na KJ, Ahn SJ, Choi S, Kim YC. Tseden-Ish M, et al. Among authors: cho hj. Respirology. 2012 Jan;17(1):127-33. doi: 10.1111/j.1440-1843.2011.02060.x. Respirology. 2012. PMID: 21899657

4

Comparison of docetaxel/cisplatin dosages of 75/60 and 60/60 mg/m(2) for the treatment of non-small cell lung cancer.

Kim KS, Oh IJ, Ban HJ, Cho HJ, Kwon YS, Kim YI, Lim SC, Na KJ, Song SY, Choi S, Choi YD, Kim YC. Kim KS, et al. Among authors: cho hj. Exp Ther Med. 2012 Aug;4(2):317-322. doi: 10.3892/etm.2012.597. Epub 2012 Jun 1. Exp Ther Med. 2012. PMID: 23139720 Free PMC article.

5

Effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer.

Yoo SS, Kang HG, Choi JE, Do SK, Lee WK, Choi SH, Lee SY, Lee SY, Lee J, Cha SI, Kim CH, Seok Y, Lee E, Kim MS, Lee JM, Cho HJ, Oh IJ, Kim YC, Cho S, Jheon S, Jung CY, Kim MH, Lee MK, Park JY. Yoo SS, et al. Among authors: cho hj, cho s. Cancer Genet. 2017 Apr;212-213:8-12. doi: 10.1016/j.cancergen.2017.03.003. Epub 2017 Mar 20. Cancer Genet. 2017. PMID: 28449811

6

A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2.

Park CK, Cho HJ, Choi YD, Oh IJ, Kim YC. Park CK, et al. Among authors: cho hj. Cancer Res Treat. 2019 Apr;51(2):777-787. doi: 10.4143/crt.2018.387. Epub 2018 Sep 7. Cancer Res Treat. 2019. PMID: 30189719 Free PMC article. Clinical Trial.

7

A Phase II Trial of Osimertinib as the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutations in Circulating Tumor DNA: LiquidLung-O-Cohort 1.

Park CK, Cho HJ, Choi YD, Oh IJ, Kim YC. Park CK, et al. Among authors: cho hj. Cancer Res Treat. 2021 Jan;53(1):93-103. doi: 10.4143/crt.2020.459. Epub 2020 Sep 21. Cancer Res Treat. 2021. PMID: 32972042 Free PMC article. Clinical Trial.

8

Comprehensive analysis of blood-based biomarkers for predicting immunotherapy benefits in patients with advanced non-small cell lung cancer.

Park CK, Oh HJ, Kim MS, Koh BG, Cho HJ, Kim YC, Yang HJ, Lee JY, Chun SM, Oh IJ. Park CK, et al. Among authors: cho hj. Transl Lung Cancer Res. 2021 May;10(5):2103-2117. doi: 10.21037/tlcr-21-100. Transl Lung Cancer Res. 2021. PMID: 34164263 Free PMC article.

9

CD8⁺ TILs in NSCLC differentiate into TEMRA via a bifurcated trajectory: deciphering immunogenicity of tumor antigens.

Lee SW, Choi HY, Lee GW, Kim T, Cho HJ, Oh IJ, Song SY, Yang DH, Cho JH. Lee SW, et al. Among authors: cho hj, cho jh. J Immunother Cancer. 2021 Sep;9(9):e002709. doi: 10.1136/jitc-2021-002709. J Immunother Cancer. 2021. PMID: 34593620 Free PMC article.

10

A method for early diagnosis of lung cancer from tumor originated DNA fragments using plasma cfDNA methylome and fragmentome profiles.

Kim YJ, Jeon H, Jeon S, Lee SH, Kim C, Ahn JH, Um H, Woo YJ, Jeong SH, Kim Y, Park HY, Oh HJ, Cho HJ, Bae JH, Kim JH, An S, Kang SB, Jho S, Biro O, Kis D, Kim BC, Kim Y, Kim JH, Kim BC, Bhak J, Oh IJ. Kim YJ, et al. Among authors: cho hj. Mol Cell Probes. 2022 Dec;66:101873. doi: 10.1016/j.mcp.2022.101873. Epub 2022 Nov 12. Mol Cell Probes. 2022. PMID: 36379302

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,994 results

Search Page

Filters